Therapeutics: UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (LpxC)

Infectious disease

INDICATION: Gram-negative bacterial infection

In vitro studies identified an analog of a diphenylacetylene-based LpxC

Read the full 145 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE